Montreal, Canada

Jon P Durkin


Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Ottawa, CA (2006 - 2009)
  • Montreal, CA (2010 - 2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jon P Durkin

Introduction

Jon P Durkin is a notable inventor based in Montreal, Canada, recognized for his significant contributions to the field of medical research and treatment. With a total of seven patents to his name, Durkin has made strides in developing methods and compounds aimed at treating serious health conditions, particularly cancer and neuronal disorders.

Latest Patents

Among his latest patents is a groundbreaking method for treating cancer using IAP antisense oligomer and chemotherapeutic agents. This invention features methods, compositions, and kits designed for treating patients with proliferative diseases. Another notable patent involves compounds of Formula I, which are utilized as neuroprotective agents in the treatment of neuronal disorders affecting both the central and peripheral nervous systems.

Career Highlights

Throughout his career, Jon P Durkin has worked with prominent companies such as Aegera Therapeutics, Inc. and Pharmascience Inc. His work in these organizations has allowed him to contribute to the advancement of medical treatments and therapies, showcasing his dedication to improving patient outcomes.

Collaborations

Durkin has collaborated with esteemed colleagues, including James B Jaquith and Alain Boudreault. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the medical field.

Conclusion

Jon P Durkin's contributions to medical innovation through his patents and collaborations highlight his commitment to advancing healthcare solutions. His work continues to impact the treatment of critical health issues, making him a significant figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…